Source: Contract Pharma

Teligent: Hikma Acquires Teligent Sterile Injectable Assets for $45.75M

Marks Hikma's expansion into Canada and includes a portfolio of 25 sterile injectable products.

Read full article »
Teligent's Competitors | Teligent's News | Teligent's Financials
Stay up-to-date with the latest news on Teligent
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Tim Sawyer's photo - President & CEO of Teligent

President & CEO

Tim Sawyer

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on Teligent